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ABSTRACT 
Abnormal vaginal discharge due to reproductive tract infections (RTls) is \\,idel!. prevalent in the 
country. According to WHO, over 300 million new cases of sexually-transmitted infections (excluding 
H ~ V )  occur each year. In addition to these, HIV infection is spreading rapidly in the country with over 
3.7 million sero-positive cases (from zero) within 15 years. The predominant mode of transmission of 
HIV is by heterosexual route. The multidrug regime for treatment is expensive (about $10.000 per year) 
which is beyond the reach of most of the people. No viable vaccine preventing AIDS infection is in sight. 
Under these circumstances, safe sex is the best recourse, which demands consistent and proper use of 
condoms. This does not take place to the extent necessary for preventing the transmission of HIV and 
other sexually-transmitted infections. A polyherbal tablet for intravaginal use by women has been developed. 
and a polyherbal cream, for use by both men and women, which has a wide spectrum antimicrobial action. 
Amongst others, these inhibit the growth of Neisseria gonorrhea (including strains resistant to penicillin). 
normal and multidrug-resistant isolates of urinary tract E. cali, Candida albicans. Candida krusei and 
Candida tropicalis. Applied intravaginally, these prevent the transmission of Herpes simpler 2 and 
Chlamydia trachomatis in progestin-sensitised mice. Studies conducted at the lnstitut Pasteur. Paris and 
Conrad Norfolk, USA, have demonstrated high virucidal action of these formulations against HIVI. Both 
formulations have undergone phase I clinical trials in five major centres in lndia and abroad. which have 
indicated the complete safety of these products without any local or systemic side effects. The Drug 
Controller of India and the Institutional Ethics Committees have approved phase [I clinical trials. The 
first of these t r ~ a l s  a a s  conducted I" 88 \rumen tr nth abndrmal \a$~naidlsih;l;$e due to genital pathogens 
at the Postaraduate Insututc of Medical Educnlion anJ Ke%earch. Chdndlearh C \ e r \  aoman. x h o  used 
- - 
thepraneem polyherbals, once every night for seven days, experienced relief clinically, irrespective of 
the nature of the causative pathogen. 
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1. INTRODUCTION 
Since late, increasing attention is being given 
to the reproductive health of women. Bang1, et al. 
reported that nearly 50 per cent of women in rural 
Maharashtra suffered from abnormal vaginal 
discharge due to reproductive tract infections 
(RTls). An independent study of Indian Council of 
Medical Research+evealed that 27 per cent to 30 
per cent of women attending ante-natal clinics in 
city hospi.tals had RTIs. The Population Foundation 
of lndia noted that nearly 80 per cent of women 
in slums have abnormal vaginal discharge due to 
RTls. The incidence of RTIs is thus high in the 
country. Women do not approach the doctors for 
these problems, due to privacy and cultural factors. 
Many feel that these are natural consequence of 
their married life. The causative organisms vary, 
ranging from (aerobic and anaerobic) microbes to 
fungi, protozoa and viruses. 
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There is also an apparent epidemic of sexually- 
transmitted infections (STls). WHO reported3 
333 million new cases of STls in the world in 1995, 
amongst which 62 million were o f  Neisseria 
gonorrhea. These figures do not include the AlDS 
pandemic raging in the country. The AIDS virus is 
of foreign origin and first noticed in India in 1986 
(leaving aside a few cases of AIDS of Indians who 
had contracted the disease overseas). Initially, the 
epicentres of infection were confined to two port 
cities, Chennai and Mumbai. To these was added 
a foyer of intravenous drug users in Manipur and 
in areas bordering Mynamar. Over the past 
15 years, the HIV infection is no longer restricted 
to the epicentres. The entire states of Tamil Nadu, 
Maharashtra and Andhra Pradesh are now endemic 
areas. In the northeast, the infection has creeped 
to West Bengal, and the entire trucks route from 
Mulnbai to Amritsar is today infected with HIV 
which IS passed on to innocent wives in villages. 
In Maharashtra, sero-positivity of monogamous 
married women coming for delivery to hospitals is 
now 0.4 per cent to 2.7 per cent. These represent 
in a way the general population and not the 
professional sex workers. We are sitting on an 
iceberg and many steps must be taken to contain 
the HIV pandemic. Awareness and education for 
safe sex is being spread by various agencies- 
although more needs to be done. The main reliance 
for safe sex is on the use of condoms. Condoms 
are largely male controlled, who do not use these 
regularly. A highly useful introduction will be the 
vaginal microbicides under full control of women. 
Development of two polyherbal formulations intended 
for this purpose has been briefly reviewed here. 
2. SPERMICIDES-CUM-MICROBICIDES 
Spermicides-cum-microbicides are available in 
the form of suppositories (pessaries), foaming tablets, 
creams, or sponges soaked with solutions of 
compoands. The most commonly used compound 
is nonoxynol-9, a powerful detergent with high 
spermicidal and microbicidal properties. Another 
compound used in some preparations is benzyl 
alkonium chloride. These compounds, while effective 
as spermicides, are cytotoxic and their repeated 
use causes inflammation of the vaginal mucosa 
and damage to the vaginal epithelium4 with the  
result that viral uptake is enhanced rather than the 
killing o f  the virus. Trials conducted in Kenya on 
professional sex workers employing nonoxynol-based 
spermicides gave the surprising results of an increased 
uptake of HIV infection5. It was postulated that - 
reduction of the concentration of nonoxynol-9 by 
slow release of formulations and coverage of the 
vaginal epithelium by bio-adhesive materials 
incorporated in the microbicide formulation may 
overcome the noxious effects of nonoxynol-9. 
Advantage-S, an improved gel, incorporating these 
features, which is marketed by a New York-based 
company, underwent phase 111 clinical trials under 
the auspices of UN-AIDS. Unfortunately, the results 
of this carefully planned trial showed that this gel 
was not effective in preventing the transmission of 
HIV infection by the vaginal route. The spermicide 
marketed in France with benzyl alkonium chloride 
as base has met with a similar fate. It failed to 
prevent the transmission of simian immunodeficiency 
virus (SIV) in monkeys by the vaginal route. At 
- 
present, there is thus no spermicide-cum-microbicide 
of proven efficacy available to women for protection 
against AlDS and sexually-trabsmitted infections. 
The contraceptive efficacy of the available 
spermicides used as a single method for preventing 
pregnancy is reported to be around 80 per cent, 
which is lower than that of steroid pills or intrauterine 
devices. In part, this low efficacy may be ascribable 
to improper use of the products . However, there 
may be scope for further potentiating the spermicidal 
properties. 
3. STRATEGY ADOPTED 
It was concluded that in a vaginal-use product, 
a higher spermicidal action is required without the 
use of nonoxynol-9 or benzyl alkonium chloride 
which damage the vaginal lining. instead of synthetic 
compounds, it was considered to use extracts of 
plants, employed traditionally for various purposes, 
which are devoid of any side effects, and may 
have spermicidal properties. 
These included neem (Azardirachta indica), 
Haldi (Curcumin longa) and others. These plants 
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have been used topically on injuries without causing 
irritation or anv undesirable side effects. These 
are even ingested without any stated systemic side 
effect. Thus small uptake of such compounds through 
- 
skin, if it were to occur, would not be harmful to 
- 
health. The author determined whether neem seed 
- 
and/or leaf extracts have spermicidal properties 
on human sperm as tested by Sander Cramer slide 
- test. This was the caseb. However, concentrations 
required to kill 100 per cent sperms in 20 r were 
high. Riar7, et al .  attempted to concentrate the 
spermicidal properties in the neem oil and 
identified a fraction, nim-76, which, according to 
them, contained most of the spermicidal activity. 
The DRDO laboratories decided to make neem oil 
and nim-76 as the basis of a method for family 
planning. Credit must be given to the pioneering 
work of Dr Riar, and to Dr Selvamurthy and his 
colleagues, for further development of this lead. 
We adopted a different strategy, in which one 
looked for odourless ancfcolourless extracts from 
neem (to avoid staining of undergarments). It was 
difficult to remove pungent odour of nee@ oil 
without loss of spermicidal properties. So, extracts 
from neem leaves which were further purified to 
obtain odourless, eolourless fraction (praneem) 
containing spermicidal activity. Fingerprint profiles 
of this fraction were developed, so that batches of 
reproducible properties could be ~ b t a i n e d ~ , ~ .  To 
potentiate the spermicidal properties, the author 
employed more than one plant-derived compounds 
endowed with spermicidal properties. Extracts of 
soapnut (Sappindus mukerosi) have been used 
for centuries for washing of hair, cleaning of delicate 
woollen garments and precious carpets. These were 
active at fairly low concentrations. To add fragrahce 
to the product, Mentha citrata oil, quality controlled 
as per gas-liquid chromatography (GLC) profiles 
and bioactivity was chosen. Interestingly, the 
combination of these three were synergistic and 
enhanced spermicidal properties by eight-to-twelve- 
fold. 
4.  WIDE SPECTRUM ANTIMICROBIAL 
ACTION 
Neem is a miracle tree1". It makes about 100 
tri, tetra and penta terpenoids of fairly complicated 
structures. The chemistry of many such compounds 
has been elucidated by the works of Siddiqui", 
GovindachariI2, Schmutterer" and others. Neem is 
reported to have antibacterialN4, antifungal, 
antivirali5, antinematode and antilarval propertiesI6. 
The mechanism by which such action is exercised 
has been studied f31 dradirachtin. It is an elegant 
two-step process1'. On one side, neem constituents 
exercise anti-feedant action on insects, which are 
discouraged to feed on neem leaves or on vegetation 
sprinkted with neem extracts. On the other side, 
Azadirachtin blocks the development of larva, acting 
as an antagonist to the action of ecdysone and 
juvenile hormone. What an ecologically sound and 
elegant way to control insects! First they do not 
feed, and if they have passed that stage, do not 
grow into new insects. The mechanism of action 
of neem components on bacteria or viruses is not 
fully known. Neem extracts do inhibit the NFKb- 
induced replication of HIV in a model experimental 
system investigated by the author in collaboration 
with Dr D.K. Biswas and Pr0fA.B. Pardee, Harvard 
Medical School, some years back. In other studies, 
it was observed that neem seed extracts activate 
macrophagesg6 and stimulate cell-mediated immune 
responsesIs. In high concentrations, given orally, 
neem seed extracts cause abortion1" and the mechanism 
is by the release of inflammatory cytokines, such 
as gamma interferon and TNFa'O, characteristic 
of Th, type of immune response. Saponins should 
have cell membrane labilising action. Praneem 
polyherbal formulations have three components, 
purified neem leaf extracts (praneem), saponins 
from Sappindus mukerosi and Menrha citrara 
oil. These are dispensed as a pessary or tablet and 
as cream. 
In collaborative studies with Dr Ashok Rattan 
and Dr Uma Banneriee at the All India Institute 
of Medical Sciences (AIIMS), the growth inhibitory 
action of thepruneem polyherbal formulations was 
. . 
observed on Neisseria gonorrhea (including 
penicillin-resistant strains), urinary tract E.co/i 
(including multidrug-resistant strains). Catidida 
albicans, Candida Krusei and Caridida iropica/is" . 
In another study carried out in collaboration with 
Dr Kevin Whalley and Sharon Achilles of Johns 
Hopkins University, pre-application of prcrtteetti 
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in vagina of progestin-sensitised mice 20 s before 
inoculation of Herpes simplex 2 prevented the 
development of lesions due to Herpes, and no 
cultivable virus was present in the vagina on days 
4 and 8 after infection. In a similar in viva experimental 
model, praneem was highly effective in blocking 
the transmission of Chlamydia trachomatis infections2'. 
The high virucidal effect ofpraneem polyherbal 
on HIV 1 has been investigated in two laboratories: 
at the lnstitut Pasteur, Paris and Conrad Norfolks, 
USA. The systems for study differed. However, 
both studies demonstrated a high virucidal action 
of praneem polyherbal on virus causing AIDS2'. 
5.  CLINICAL EVALUATION 
Pre-clinical toxicology studies were conducted 
in rats and monkeys, which showed the safety of 
praneem p ~ l y h e r h a l ~ ~ .  Draize test on braided skin 
of rabbits and cumulative studies on human skin 
indicated the lack of irritability of the formulation2'. 
After due permission of the Drugs Controller of 
lndia and lnstitutional Ethics Committees, phase 1 
clinical trials were conducted with the praneem 
polyherbal pessary in 23 women at three centres, 
namely Postgraduate Institute of Medical Education 
and Research, Chandigarh (PGIMER), Safdarjung 
Hospital, New Delhi and Kamla Nehru Hospital, 
Allahabad. These consisted of local reactions, if 
any, effect on vaginal cytology, and on systemic 
indices of hematology, blood chemistry and organ 
functions after seven consecutive days of intravaginal 
application of praneem polyherbal pessary. 
Phase I clinical studies with the praneem cream 
were also carried out in Brazil. These studies showed 
the safety and lack oftoxicity ofpraneem polyherbal 
formulations. 
Phase I1 efficacy studies were undertaken in 
women suffering from abnormal vaginal discharge 
due to RTls. These studies had the clearance of 
the Drugs Controller of lndia and the Institutional 
Ethics Committees. The Population Foundation of 
lndia funded the study at the PGIMER, Chandigarh. 
The efficacy was studied in 88 women enrolled on 
the basis of thorough clinical and microbiological 
examinations. Women were prescribed to insert 
ITraneent polyherbal pessaryltablet high in the vagina 
with washed fingers every night for seven days 
and report back to the clinic on the loth day. Every 
woman who completed the study experienced relief 
of symptoms, which was confirmed by clinical 
examination. Microbiological assays showed the 
elimination or reduction of the pathogens. Efficacy 
was seen in women ~rrespective of the nature of - 
the causative pathogen. Pessary required wetting 
before insertion, which women did not always jr 
remember. It has since been converted into the 
tablet form with change of vehicle, which does not 
require wetting. Moreover, the tablet does not soften 
on storage at prevalent temperatures in summer, 
making its use feasible in homes which do not have 
refrigerators. Although the active principles of pessary 
and tablet are identical, to confirm safety of the 
tablet, another round of phase I clinical studies 
were conducted in 20 women at two centres-the 
Institute for Research in Reproduction, Mumbai 
and PGI, Chandigarh. Both studies have shown the 
complete safety of the praneem polyherbal tablet. 
The tablet has also registered a high acceptability 
from the users. Praneem polyherbal tablets or pessaries 
- 
are both effective in curing RTIs as per the first 
phase 11 studies. Efficacy trials are now being 
extended to five centres located in different parts 
of the country. 
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